These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 30214155)

  • 21. [Pitolisant for the treatment of narcolepsy with or without cataplexy].
    Bruhn C
    Med Monatsschr Pharm; 2016 Aug; 39(8):324-9. PubMed ID: 29984945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the treatment of narcolepsy: clinical efficacy of pitolisant.
    Calik MW
    Nat Sci Sleep; 2017; 9():127-133. PubMed ID: 28490912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of sodium oxybate as a treatment option for narcolepsy.
    Abad VC
    Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215
    [No Abstract]   [Full Text] [Related]  

  • 24. Real-world treatment of pediatric narcolepsy with pitolisant: A retrospective, multicenter study.
    Triller A; Pizza F; Lecendreux M; Lieberich L; Rezaei R; Pech de Laclause A; Vandi S; Plazzi G; Kallweit U
    Sleep Med; 2023 Mar; 103():62-68. PubMed ID: 36758348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of pitolisant in patients with high burden of narcolepsy symptoms: pooled analysis of short-term, placebo-controlled studies.
    Davis CW; Kallweit U; Schwartz JC; Krahn LE; Vaughn B; Thorpy MJ
    Sleep Med; 2021 May; 81():210-217. PubMed ID: 33721598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Advances in treatment of narcolepsy].
    Xu Q; Lou G; Wang T; Zhang L
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 49(4):419-424. PubMed ID: 32985153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ
    Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma-hydroxybutyrate (GHB) for narcolepsy in adults: an updated systematic review and meta-analysis.
    Xu XM; Wei YD; Liu Y; Li ZX
    Sleep Med; 2019 Dec; 64():62-70. PubMed ID: 31671326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological management of narcolepsy with and without cataplexy.
    Kallweit U; Bassetti CL
    Expert Opin Pharmacother; 2017 Jun; 18(8):809-817. PubMed ID: 28443381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment Options for Narcolepsy.
    Barateau L; Lopez R; Dauvilliers Y
    CNS Drugs; 2016 May; 30(5):369-79. PubMed ID: 27155860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.
    McClellan KJ; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):311-24. PubMed ID: 27521015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European guideline and expert statements on the management of narcolepsy in adults and children.
    Bassetti CLA; Kallweit U; Vignatelli L; Plazzi G; Lecendreux M; Baldin E; Dolenc-Groselj L; Jennum P; Khatami R; Manconi M; Mayer G; Partinen M; Pollmächer T; Reading P; Santamaria J; Sonka K; Dauvilliers Y; Lammers GJ
    Eur J Neurol; 2021 Sep; 28(9):2815-2830. PubMed ID: 34173695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Pitolisant on the Treatment of Narcolepsy: A Systematic Review.
    Fabara SP; Ortiz JF; Anas Sohail A; Hidalgo J; Altamimi A; Tama B; Patel UK
    Cureus; 2021 Jul; 13(7):e16095. PubMed ID: 34345566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recently Approved and Upcoming Treatments for Narcolepsy.
    Thorpy MJ
    CNS Drugs; 2020 Jan; 34(1):9-27. PubMed ID: 31953791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J; Swick T; Bogan R; Lai C; Carter LP
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives.
    Abad VC
    Nat Sci Sleep; 2021; 13():75-91. PubMed ID: 33531850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav
    Heo YA
    CNS Drugs; 2022 May; 36(5):541-549. PubMed ID: 35357671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. European guideline and expert statements on the management of narcolepsy in adults and children.
    Bassetti CLA; Kallweit U; Vignatelli L; Plazzi G; Lecendreux M; Baldin E; Dolenc-Groselj L; Jennum P; Khatami R; Manconi M; Mayer G; Partinen M; Pollmächer T; Reading P; Santamaria J; Sonka K; Dauvilliers Y; Lammers GJ
    J Sleep Res; 2021 Dec; 30(6):e13387. PubMed ID: 34173288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of modafinil and pitolisant in narcolepsy: a non-inferiority meta-analytical approach.
    Lehert P; Szoeke C
    Drugs Context; 2020; 9():. PubMed ID: 32699548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.